Cardinal Health EVP Sells $345,021 in Stock (CAH)
Cardinal Health (NYSE:CAH) EVP Mark R. Blake sold 4,782 shares of the company’s stock on the open market in a transaction dated Monday, August 18th. The stock was sold at an average price of $72.15, for a total value of $345,021.30. Following the sale, the executive vice president now directly owns 22,589 shares in the company, valued at approximately $1,629,796. The sale was disclosed in a document filed with the SEC, which is available at this link.
A number of analysts have recently weighed in on CAH shares. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $77.93.
Shares of Cardinal Health (NYSE:CAH) traded up 0.54% on Tuesday, hitting $72.60. 1,824,200 shares of the company’s stock traded hands. Cardinal Health has a one year low of $49.65 and a one year high of $74.40. The stock has a 50-day moving average of $71.03 and a 200-day moving average of $69.58. The company has a market cap of $24.441 billion and a price-to-earnings ratio of 21.37.
Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 1.89%. The ex-dividend date is Monday, September 29th.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.